Immunizations services, convenience packaging, and more!
PCV13 Significantly Reduces Invasive Pneumococcal Disease in Pediatric Patients
Researchers explore trends from 2014 to 2022 among pediatric invasive pneumococcal diseases since introduction of the 13-valent pneumococcal conjugate vaccine.
Looking to the Future of Independent Pharmacy
Don Arthur, RPh, discusses what lays ahead in independent pharmacy, from clinical care to success stories.
Expert: For Every 1 Measles Case, There Are Expected to Be 12 to 18 More
Crystal Hodge discusses R naughts and the measures of how contagious measles is.
Easing The Burden of Burnout With Technology
Lani Bertrand, RPh, joins the latest episode of Over The Counter to discuss the role of technology in easing burnout during the COVID-19 pandemic.
ACIP Votes to Expand RSV Vaccine Recommendation to Include Adults 50 Years and Older
Currently, the recommendation is for patients 75 years and older and those aged 60 to 74 years with an increased risk of severe respiratory syncytial virus.
ACIP Votes to Recommend the Use of MenABCWY in Adolescent Vaccine Schedule
The FDA approved Penmenvy in February 2025 for use in patients aged 10 to 25 years.